Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Aneurysm & intracranial embolization · Oregon | Aneurysm & intracranial embolization · California | |
|---|---|---|
| Surgeons, 2024 | 2 | 48 |
| Medicare fee-for-service cases | 108 | 1,774 |
| Growth since 2019 (Medicare FFS) | +11%/yr | +17%/yr |
| Forecast cases (Medicare FFS) | 150 in 2030 | 3,530 in 2030 |
| Forecast growth | +5.8%/yr to 2030 | +12%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.3 | 0.5 |
| Medicare Advantage share | 59% | 56% |
| Out of hospital | 0% | 0% (+0 pts since 2019) |
| Cases per surgeon | 54 | 37 |
| Top 10 surgeons' share | 100% | 37% |
| Surgeons growing | 0 | 3 |
| New since the base year | 0 | 16 |
| Likely to stop billing it | 2 by 2026 | 18 by 2026 |
| Forecast miss, 1 year (procedure) | 13% | 13% |
| Company payments per surgeon | $26K | $32K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.